BRIGHTON LOVEDAY: Open Payments
NPI 1871865071 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,683 in 77 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,683
Food & beverage: $1,683
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $251 |
| PFIZER INC. | 15 | $211 |
| ABBVIE INC. | 7 | $157 |
| Janssen Biotech, Inc. | 8 | $154 |
| ARRAY BIOPHARMA INC | 5 | $91 |
| Merck Sharp & Dohme LLC | 3 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $79 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
| PUMA BIOTECHNOLOGY, INC. | 4 | $71 |
| Daiichi Sankyo Inc. | 2 | $58 |
Products named: DATROWAY, PADCEV, KEYTRUDA, Nubeqa, KISQALI, LORBRENA, NERLYNX, EPKINLY.
Industry payments across UT — which companies pay providers there.
